Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

2.

Halo and spillover effect illustrations for selected beneficial medical devices and drugs.

Kerger BD, Bernal A, Paustenbach DJ, Huntley-Fenner G.

BMC Public Health. 2016 Sep 15;16:979. doi: 10.1186/s12889-016-3595-7.

3.

Pathology, toxicology, and latency of irritant gases known to cause bronchiolitis obliterans disease: Does diacetyl fit the pattern?

Kerger BD, Fedoruk MJ.

Toxicol Rep. 2015 Nov 2;2:1463-1472. doi: 10.1016/j.toxrep.2015.10.012. eCollection 2015. Review.

4.

Review of cobalt toxicokinetics following oral dosing: Implications for health risk assessments and metal-on-metal hip implant patients.

Tvermoes BE, Paustenbach DJ, Kerger BD, Finley BL, Unice KM.

Crit Rev Toxicol. 2015 May;45(5):367-87. doi: 10.3109/10408444.2014.985818. Epub 2015 Jan 28. Review.

PMID:
25629922
5.

Evaluation of four α-diketones for toll-like receptor-4 (TLR-4) activation in a human transfected cell line.

Kerger BD, Thuett KA, Finley BL.

Food Chem Toxicol. 2014 Dec;74:117-9. doi: 10.1016/j.fct.2014.09.010. Epub 2014 Oct 2.

PMID:
25280922
6.

Tumors that mimic asbestos-related mesothelioma: time to consider a genetics-based tumor registry?

Kerger BD, James RC, Galbraith DA.

Front Genet. 2014 May 30;5:151. doi: 10.3389/fgene.2014.00151. eCollection 2014.

7.

Screening level health risk assessment of selected metals in apple juice sold in the United States.

Tvermoes BE, Banducci AM, Devlin KD, Kerger BD, Abramson MM, Bebenek IG, Monnot AD.

Food Chem Toxicol. 2014 Sep;71:42-50. doi: 10.1016/j.fct.2014.05.015. Epub 2014 Jun 2.

PMID:
24882758
8.

Refined biokinetic model for humans exposed to cobalt dietary supplements and other sources of systemic cobalt exposure.

Unice KM, Kerger BD, Paustenbach DJ, Finley BL, Tvermoes BE.

Chem Biol Interact. 2014 Jun 5;216:53-74. doi: 10.1016/j.cbi.2014.04.001. Epub 2014 Apr 13.

PMID:
24726710
9.

31-day study of cobalt(II) chloride ingestion in humans: pharmacokinetics and clinical effects.

Finley BL, Unice KM, Kerger BD, Otani JM, Paustenbach DJ, Galbraith DA, Tvermoes BE.

J Toxicol Environ Health A. 2013;76(21):1210-24. doi: 10.1080/15287394.2013.848391.

PMID:
24283372
10.

An evidence-based analysis of epidemiologic associations between lymphatic and hematopoietic cancers and occupational exposure to gasoline.

Keenan JJ, Gaffney S, Gross SA, Ronk CJ, Paustenbach DJ, Galbraith D, Kerger BD.

Hum Exp Toxicol. 2013 Oct;32(10):1007-27. doi: 10.1177/0960327113476909. Epub 2013 Jun 5.

PMID:
23739846
11.

A review of the health hazards posed by cobalt.

Paustenbach DJ, Tvermoes BE, Unice KM, Finley BL, Kerger BD.

Crit Rev Toxicol. 2013 Apr;43(4):316-62. doi: 10.3109/10408444.2013.779633. Review.

PMID:
23656559
12.

The University of Michigan Dioxin Exposure Study: estimating residential soil and house dust exposures to young children.

Paustenbach DJ, Kerger BD.

Chemosphere. 2013 Apr;91(2):200-4. doi: 10.1016/j.chemosphere.2012.12.047. Epub 2013 Jan 22.

PMID:
23351485
13.

A calibrated human PBPK model for benzene inhalation with urinary bladder and bone marrow compartments.

Knutsen JS, Kerger BD, Finley B, Paustenbach DJ.

Risk Anal. 2013 Jul;33(7):1237-51. doi: 10.1111/j.1539-6924.2012.01927.x. Epub 2012 Dec 24.

PMID:
23278103
14.

Airborne benzene exposures from cleaning metal surfaces with small volumes of petroleum solvents.

Hollins DM, Kerger BD, Unice KM, Knutsen JS, Madl AK, Sahmel JE, Paustenbach DJ.

Int J Hyg Environ Health. 2013 Jun;216(3):324-32. doi: 10.1016/j.ijheh.2012.08.008. Epub 2012 Oct 22.

PMID:
23088855
15.

Re-analysis of Ranch Hand study supports reverse causation hypothesis between dioxin and diabetes.

Kerger BD, Scott PK, Pavuk M, Gough M, Paustenbach DJ.

Crit Rev Toxicol. 2012 Sep;42(8):669-87. doi: 10.3109/10408444.2012.694095. Epub 2012 Jun 21. Review.

PMID:
22720712
16.

Tenuous dose-response correlations for common disease states: case study of cholesterol and perfluorooctanoate/sulfonate (PFOA/PFOS) in the C8 Health Project.

Kerger BD, Copeland TL, DeCaprio AP.

Drug Chem Toxicol. 2011 Oct;34(4):396-404. doi: 10.3109/01480545.2011.582502. Epub 2011 Jul 19. Review.

PMID:
21770727
17.

Chromium(VI) ingestion and cancer.

Kerger BD, Butler WJ, Ye T, Li S.

Epidemiology. 2009 Jul;20(4):627-8; author reply 628. doi: 10.1097/EDE.0b013e3181a99712. No abstract available.

PMID:
19525697
18.

Cancer mortality in chinese populations surrounding an alloy plant with chromium smelting operations.

Kerger BD, Butler WJ, Paustenbach DJ, Zhang J, Li S.

J Toxicol Environ Health A. 2009;72(5):329-44. doi: 10.1080/15287390802529898.

PMID:
19184749
19.

Concentration and age-dependent elimination kinetics of polychlorinated dibenzofurans in Yucheng and Yusho patients.

Leung HW, Kerger BD, Paustenbach DJ, Ryan JJ, Masuda Y.

Toxicol Ind Health. 2007 Sep;23(8):493-501.

PMID:
18669171
20.

An adaptable internal dose model for risk assessment of dietary and soil dioxin exposures in young children.

Kerger BD, Leung HW, Scott PK, Paustenbach DJ.

Toxicol Sci. 2007 Nov;100(1):224-37. Epub 2007 Aug 6.

PMID:
17682006
21.

Refinements on the age-dependent half-life model for estimating child body burdens of polychlorodibenzodioxins and dibenzofurans.

Kerger BD, Leung HW, Scott PK, Paustenbach DJ.

Chemosphere. 2007 Apr;67(9):S272-8. Epub 2007 Jan 17.

PMID:
17207842
22.

Age- and concentration-dependent elimination half-life of 2,3,7,8-tetrachlorodibenzo-p-dioxin in Seveso children.

Kerger BD, Leung HW, Scott P, Paustenbach DJ, Needham LL, Patterson DG Jr, Gerthoux PM, Mocarelli P.

Environ Health Perspect. 2006 Oct;114(10):1596-602.

23.

Identifying soil cleanup criteria for dioxins in urban residential soils: how have 20 years of research and risk assessment experience affected the analysis?

Paustenbach DJ, Fehling K, Scott P, Harris M, Kerger BD.

J Toxicol Environ Health B Crit Rev. 2006 Mar-Apr;9(2):87-145. Review.

PMID:
16613806
24.

Elimination half-lives of selected polychlorinated dibenzodioxins and dibenzofurans in breast-fed human infants.

Leung HW, Kerger BD, Paustenbach DJ.

J Toxicol Environ Health A. 2006 Mar;69(6):437-43.

PMID:
16574620
25.

Ammonia exposure and hazard assessment for selected household cleaning product uses.

Fedoruk MJ, Bronstein R, Kerger BD.

J Expo Anal Environ Epidemiol. 2005 Nov;15(6):534-44.

PMID:
16030526
26.

Airborne exposure to trihalomethanes from tap water in homes with refrigeration-type and evaporative cooling systems.

Kerger BD, Suder DR, Schmidt CE, Paustenbach DJ.

J Toxicol Environ Health A. 2005 Mar 26;68(6):401-29.

PMID:
15799243
27.

Development of an oral cancer slope factor for Aroclor 1268.

Warren DA, Kerger BD, Britt JK, James RC.

Regul Toxicol Pharmacol. 2004 Aug;40(1):42-53.

PMID:
15265605
28.

Benzene exposure assessment for use of a mineral spirits-based degreaser.

Fedoruk MJ, Bronstein R, Kerger BD.

Appl Occup Environ Hyg. 2003 Oct;18(10):764-71.

PMID:
12959887
29.

Human health risk and exposure assessment of chromium (VI) in tap water.

Paustenbach DJ, Finley BL, Mowat FS, Kerger BD.

J Toxicol Environ Health A. 2003 Jul 25;66(14):1295-339.

PMID:
12851114
30.

Measurement of volatile organic compounds inside automobiles.

Fedoruk MJ, Kerger BD.

J Expo Anal Environ Epidemiol. 2003 Jan;13(1):31-41.

31.

A physiologically based model for the ingestion of chromium(III) and chromium(VI) by humans.

O'Flaherty EJ, Kerger BD, Hays SM, Paustenbach DJ.

Toxicol Sci. 2001 Apr;60(2):196-213.

PMID:
11248132
32.

Assessment of airborne exposure to trihalomethanes from tap water in residential showers and baths.

Kerger BD, Schmidt CE, Paustenbach DJ.

Risk Anal. 2000 Oct;20(5):637-51.

PMID:
11110211
33.

In vitro reduction kinetics of hexavalent chromium in human blood.

Corbett GE, Dodge DG, O'Flaherty E, Liang J, Throop L, Finley BL, Kerger BD.

Environ Res. 1998 Jul;78(1):7-11.

PMID:
9630439
34.

Systemic uptake of chromium in human volunteers following dermal contact with hexavalent chromium (22 mg/L).

Corbett GE, Finley BL, Paustenbach DJ, Kerger BD.

J Expo Anal Environ Epidemiol. 1997 Apr-Jun;7(2):179-89.

PMID:
9185011
35.

Estimates of the chromium(VI) reducing capacity in human body compartments as a mechanism for attenuating its potential toxicity and carcinogenicity.

De Flora S, Camoirano A, Bagnasco M, Bennicelli C, Corbett GE, Kerger BD.

Carcinogenesis. 1997 Mar;18(3):531-7.

PMID:
9067553
36.

Ingestion of chromium(VI) in drinking water by human volunteers: absorption, distribution, and excretion of single and repeated doses.

Kerger BD, Finley BL, Corbett GE, Dodge DG, Paustenbach DJ.

J Toxicol Environ Health. 1997 Jan;50(1):67-95.

PMID:
9015133
37.

Human ingestion of chromium (VI) in drinking water: pharmacokinetics following repeated exposure.

Finley BL, Kerger BD, Katona MW, Gargas ML, Corbett GC, Paustenbach DJ.

Toxicol Appl Pharmacol. 1997 Jan;142(1):151-9.

PMID:
9007044
38.

Observation of steady state in blood and urine following human ingestion of hexavalent chromium in drinking water.

Paustenbach DJ, Hays SM, Brien BA, Dodge DG, Kerger BD.

J Toxicol Environ Health. 1996 Dec 6;49(5):453-61.

PMID:
8968407
39.

Absorption and elimination of trivalent and hexavalent chromium in humans following ingestion of a bolus dose in drinking water.

Kerger BD, Paustenbach DJ, Corbett GE, Finley BL.

Toxicol Appl Pharmacol. 1996 Nov;141(1):145-58.

PMID:
8917687
40.

Measurement of DNA-protein cross-links in human leukocytes following acute ingestion of chromium in drinking water.

Kuykendall JR, Kerger BD, Jarvi EJ, Corbett GE, Paustenbach DJ.

Carcinogenesis. 1996 Sep;17(9):1971-7.

PMID:
8824522
41.

Assessment of airborne hexavalent chromium in the home following use of contaminated tapwater.

Finley BL, Kerger BD, Dodge DG, Meyers SM, Richter RO, Paustenbach DJ.

J Expo Anal Environ Epidemiol. 1996 Apr-Jun;6(2):229-45.

PMID:
8792299
42.

Refined exposure assessment for ingestion of tapwater contaminated with hexavalent chromium: consideration of exogenous and endogenous reducing agents.

Kerger BD, Richter RO, Chute SM, Dodge DG, Overman SK, Liang J, Finley BL, Paustenbach DJ.

J Expo Anal Environ Epidemiol. 1996 Apr-Jun;6(2):163-79.

PMID:
8792295
43.

Chromium (VI) at plausible drinking water concentrations is not genotoxic in the in vivo bone marrow micronucleus or liver unscheduled DNA synthesis assays.

Mirsalis JC, Hamilton CM, O'Loughlin KG, Paustenbach DJ, Kerger BD, Patierno S.

Environ Mol Mutagen. 1996;28(1):60-3. No abstract available.

PMID:
8698048
44.

Antagonism of bromobenzene-induced hepatotoxicity by the alpha-adrenoreceptor blocking agents phentolamine and idazoxan: role of hypothermia.

Kerger BD, Roberts SM, Harbison RD, James RC.

Toxicol Appl Pharmacol. 1989 Feb;97(2):360-9.

PMID:
2564219
45.

Comparison of human and mouse liver microsomal metabolism of bromobenzene and chlorobenzene to 2- and 4-halophenols.

Kerger BD, Roberts SM, James RC.

Drug Metab Dispos. 1988 Sep-Oct;16(5):672-7.

PMID:
2906588
46.

Antagonism of bromobenzene-induced hepatotoxicity by phentolamine: evidence for a metabolism-independent intervention.

Kerger BD, Roberts SM, Hinson JA, Gandy J, Harbison RD, James RC.

Toxicol Appl Pharmacol. 1988 Aug;95(1):24-31.

PMID:
2901149
47.

Antagonism of bromobenzene-induced hepatotoxicity by the alpha-adrenergic blocking agents, phentolamine and idazoxan.

Kerger BD, Gandy J, Bucci TJ, Roberts SM, Harbison RD, James RC.

Toxicol Appl Pharmacol. 1988 Aug;95(1):12-23.

PMID:
2901148
48.

An assay for phentolamine using high performance liquid chromatography with electrochemical detection.

Kerger BD, James RC, Roberts SM.

Anal Biochem. 1988 Apr;170(1):145-51.

PMID:
3389507

Supplemental Content

Loading ...
Support Center